Status:
COMPLETED
Pilot Study of Allergy Immunotherapy and Prevention of Viral Respiratory Infections
Lead Sponsor:
West Penn Allegheny Health System
Collaborating Sponsors:
Pennsylvania Allergy and Asthma Research Foundation
Conditions:
Allergy
Seasonal Allergic Rhinitis
Eligibility:
All Genders
6-18 years
Brief Summary
The objective of this study is to determine whether there is a relationship between interferon-gamma levels and the incidence of viral respiratory infections in allergic children treated with allergy ...
Detailed Description
This study will consist of five visits. Visit 1 will occur after subjects complete an initial clinical evaluation for allergy at this site. Subjects will select their treatment (allergy immunotherapy ...
Eligibility Criteria
Inclusion
- Age 6-18 years of age
- History of allergic rhinitis as confirmed by previous allergy skin testing conducted within the past year
- Subjects assigned to the allergy immunotherapy must be prescribed therapy according to national recommendations using FDA-approved allergy extracts supplied by Greer Laboratories
Exclusion
- Concurrent difficult to control asthma or an underlying immune deficiency
Key Trial Info
Start Date :
October 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2009
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00405899
Start Date
October 1 2006
End Date
December 1 2009
Last Update
May 31 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Allegheny General Hospital
Pittsburgh, Pennsylvania, United States, 15212